ReviewBiomedicines2025
Diffusion Tensor Imaging-Based Glymphatic Dysfunction Assessments in Migraine Syndromes: Mechanisms and Diagnostic Implications.
Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Migraine is a common neurological disorder. Impaired glymphatic clearance has been recently implicated in the pathogenesis of migraine. Diffusion tensor imaging (DTI) metrics have been explored as a tool for assessing glymphatic status. The objective is to summarize recent advances in identifying potentially useful DTI metrics in migraine patient populations. Since 2020, there has been mixed evidence regarding the applicability of various DTI metrics in migraine subpopulations. Most studies focused on whole-brain analyses, or specified regions of interest along the perivascular space, to extract quantitative parameters; most studies compared differences in these parameters associated with a migraine diagnosis, or were aiming to assess correlation between these parameters and migraine subtypes. Thus, early studies have demonstrated conflicting results regarding the utility and applicability of DTI for migraine. Greater insight into the molecular basis between migraine pathophysiology and the glymphatic system might help shape approaches to analyzing DTI data for migraine patients. Future studies incorporating larger cohorts and integrating advanced data analytics may provide additional information for the role of DTI in migraine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.